CLINICAL_TRIALS
trial_result
· 2016-04-05
Clinical Trial Update: A Study of Xenical (Orlistat) in Overweight and Obese Adolescents [Phase 3]
Summary
A Phase 3 trial of Xenical (orlistat) in overweight and obese adolescents has completed. The snippet does not provide trial results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Obesity | Phase 3 | Status: COMPLETED